Disposition of propofol administered as constant rate intravenous infusions in humans
- PMID: 3500657
Disposition of propofol administered as constant rate intravenous infusions in humans
Abstract
The disposition of the intravenous anesthetic propofol was studied when administered as a constant rate infusion at 3, 6, and 9 mg.kg-1.hr-1 for at least 2 hr to three groups of six patients each undergoing surgery under regional anesthesia. Arterial blood samples were collected at selected times during and up to 8 hr after infusion. Whole blood propofol concentrations were determined by high-performance liquid chromatography with fluorescence detection. Using a non-linear least-squares regression analysis, the individual data sets were best fitted by a three-compartment open mamillary model with central elimination in 17 patients. In one patient a biexponential equation was more appropriate. Derived pharmacokinetic parameters expressed as mean values +/- SD indicated an initial fast distribution (t1/2 pi; 2.8 +/- 1.2 min), with an intermediate phase (t1/2 alpha; 31.4 +/- 14.7 min), and a long terminal phase (t1/2 beta; 355 +/- 227 min), a large volume of distribution at steady state (Vss, 287 +/- 213 L), and a high blood clearance (Clb, 1.7 +/- 0.3 L/min). The function of drug in the central compartment in the terminal phase was low (Fc, 0.02). The elimination rate constant (K10, 0.1190 +/- 0.0351 min-1) was large compared with the other transfer rate constants and was responsible for the large amount of drug eliminated during distribution. The fraction of drug eliminated during the terminal phase amounted to 0.28. The slow return of drug from remote tissues (K31, 0.0033 +/- 0.0013 min-1) was rate limiting in the ultimate elimination.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Pharmacokinetics of intravenously administered meptazinol during general anaesthesia in man.Eur J Anaesthesiol. 1987 Jan;4(1):35-43. Eur J Anaesthesiol. 1987. PMID: 3582376
-
Fentanyl pre-treatment does not affect the pharmacokinetic profile of an induction dose of propofol in adults.Eur J Anaesthesiol. 1994 Mar;11(2):89-93. Eur J Anaesthesiol. 1994. PMID: 8174540 Clinical Trial.
-
Pharmacokinetics of propofol ('Diprivan') as an induction agent.Postgrad Med J. 1985;61 Suppl 3:55-7. Postgrad Med J. 1985. PMID: 3877295
-
Pharmacokinetic implications for the clinical use of propofol.Clin Pharmacokinet. 1989 Nov;17(5):308-26. doi: 10.2165/00003088-198917050-00002. Clin Pharmacokinet. 1989. PMID: 2684471 Review.
-
Propofol: a new intravenous anesthetic.Anesthesiology. 1989 Aug;71(2):260-77. Anesthesiology. 1989. PMID: 2667401 Review. No abstract available.
Cited by
-
[Accuracy of target-controlled infusion (TCI) with 2 different propofol formulations].Anaesthesist. 2004 Oct;53(10):937-43. doi: 10.1007/s00101-004-0753-6. Anaesthesist. 2004. PMID: 15372176 German.
-
Propofol Upregulates MicroRNA-30b to Inhibit Excessive Autophagy and Apoptosis and Attenuates Ischemia/Reperfusion Injury In Vitro and in Patients.Oxid Med Cell Longev. 2022 Mar 30;2022:2109891. doi: 10.1155/2022/2109891. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35401922 Free PMC article.
-
Continuous Fentanyl Background Infusion Regimen Optimised by Patient-Controlled Analgesia for Acute Postoperative Pain Management: A Randomised Controlled Trial.J Clin Med. 2020 Jan 13;9(1):211. doi: 10.3390/jcm9010211. J Clin Med. 2020. PMID: 31941001 Free PMC article.
-
Pharmacokinetics of eltanolone following bolus injection and constant rate infusion.J Pharmacokinet Biopharm. 1996 Dec;24(6):535-49. doi: 10.1007/BF02353479. J Pharmacokinet Biopharm. 1996. PMID: 9300349
-
Propofol: a review of its role in pediatric anesthesia and sedation.CNS Drugs. 2015 Jul;29(7):543-63. doi: 10.1007/s40263-015-0259-6. CNS Drugs. 2015. PMID: 26290263 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous